Ignite Creation Date:
2024-10-25 @ 7:57 PM
Last Modification Date:
2024-10-26 @ 3:38 PM
Study NCT ID:
NCT06573099
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-08-08
Brief Title:
A Real-World Study on Extranodal Lymphoma
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A Real-World Study on Extranodal Lymphoma
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The aim of this study is to prospectively collect clinical information on patients with extranodal lymphoma and to explore the best therapeutic strategies in the real-world population
Detailed Description:
Lymphoma is a common hematological malignancy Many different pathologic types of lymphoma can originate in extranodal organs or be associated with extranodal organ involvement For lymphoma with extranodal involvement conventional regimens often cannot provide satisfactory results for patients This study aims to prospectively collect clinical information on patients with extranodal DLBCL including the distribution of involved sites clinical and molecular characteristics of different lymphoma subtypes clinical treatment protocols and prognosis to explore the the best therapeutic strategies in the real-world population
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None